Creator: IMARC Group
License: https://www.imarcgroup.com/privacy-policy
Keywords: United States Vaccines Market Report

United States Vaccines Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A19991

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Vaccines Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Vaccines Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Vaccines Market - Breakup by Technology
6.1 Conjugate Vaccines
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Inactivated and Subunit Vaccines
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.3 Live Attenuated Vaccines
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
6.4 Recombinant Vaccines
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Forecast (2024-2032)
6.5 Toxoid Vaccines
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2018-2023)
6.5.3 Market Forecast (2024-2032)
6.6 Others
6.6.1 Historical and Current Market Trends (2018-2023)
6.6.2 Market Forecast (2024-2032)
7 United States Vaccines Market - Breakup by Patient Type
7.1 Pediatric
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Adult
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
8 United States Vaccines Market - Breakup by Indication
8.1 Bacterial Diseases
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.3.1 Meningococcal Disease
8.1.3.2 Pneumococcal Disease
8.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
8.1.3.4 Tuberculosis
8.1.3.5 Haemophilus Influenzae (Hib)
8.1.3.6 Typhoid
8.1.3.7 Others
8.1.4 Market Forecast (2024-2032)
8.2 Viral Diseases
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.3.1 Hepatitis
8.2.3.2 Influenza
8.2.3.3 Human Papillomavirus (HPV)
8.2.3.4 Measles/Mumps/Rubella (MMR)
8.2.3.5 Rotavirus
8.2.3.6 Herpes Zoster
8.2.3.7 Varicella
8.2.3.8 Japanese Encephalitis
8.2.3.9 Rubella
8.2.3.10 Polio
8.2.3.11 Rabies
8.2.3.12 Dengue
8.2.3.13 Others
8.2.4 Market Forecast (2024-2032)
9 United States Vaccines Market - Breakup by Route of Administration
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Oral Administration
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Others
9.3.1 Historical and Current Market Trends (2018-2023)
9.3.2 Market Forecast (2024-2032)
10 United States Vaccines Market - Breakup by Product Type
10.1 Multivalent Vaccine
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Forecast (2024-2032)
10.2 Monovalent Vaccine
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Forecast (2024-2032)
11 United States Vaccines Market - Breakup by Treatment Type
11.1 Preventive Vaccine
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2018-2023)
11.1.3 Market Forecast (2024-2032)
11.2 Therapeutic Vaccine
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2018-2023)
11.2.3 Market Forecast (2024-2032)
12 United States Vaccines Market - Breakup by End User
12.1 Hospitals
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2018-2023)
12.1.3 Market Forecast (2024-2032)
12.2 Clinics
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2018-2023)
12.2.3 Market Forecast (2024-2032)
12.3 Vaccination Centers
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2018-2023)
12.3.3 Market Forecast (2024-2032)
12.4 Academic and Research Institutes
12.4.1 Overview
12.4.2 Historical and Current Market Trends (2018-2023)
12.4.3 Market Forecast (2024-2032)
12.5 Others
12.5.1 Historical and Current Market Trends (2018-2023)
12.5.2 Market Forecast (2024-2032)
13 United States Vaccines Market - Breakup by Distribution Channel
13.1 Hospital Pharmacies
13.1.1 Overview
13.1.2 Historical and Current Market Trends (2018-2023)
13.1.3 Market Forecast (2024-2032)
13.2 Retail Pharmacies
13.2.1 Overview
13.2.2 Historical and Current Market Trends (2018-2023)
13.2.3 Market Forecast (2024-2032)
13.3 Institutional Sales
13.3.1 Overview
13.3.2 Historical and Current Market Trends (2018-2023)
13.3.3 Market Forecast (2024-2032)
13.4 Others
13.4.1 Historical and Current Market Trends (2018-2023)
13.4.2 Market Forecast (2024-2032)
14 United States Vaccines Market – Breakup by Region
14.1 Northeast
14.1.1 Overview
14.1.2 Historical and Current Market Trends (2018-2023)
14.1.3 Market Breakup by Technology
14.1.4 Market Breakup by Patient Type
14.1.5 Market Breakup by Indication
14.1.6 Market Breakup by Route of Administration
14.1.7 Market Breakup by Product Type
14.1.8 Market Breakup by Treatment Type
14.1.9 Market Breakup by End User
14.1.10 Market Breakup by Distribution Channel
14.1.11 Key Players
14.1.12 Market Forecast (2024-2032)
14.2 Midwest
14.2.1 Overview
14.2.2 Historical and Current Market Trends (2018-2023)
14.2.3 Market Breakup by Technology
14.2.4 Market Breakup by Patient Type
14.2.5 Market Breakup by Indication
14.2.6 Market Breakup by Route of Administration
14.2.7 Market Breakup by Product Type
14.2.8 Market Breakup by Treatment Type
14.2.9 Market Breakup by End User
14.2.10 Market Breakup by Distribution Channel
14.2.11 Key Players
14.2.12 Market Forecast (2024-2032)
14.3 South
14.3.1 Overview
14.3.2 Historical and Current Market Trends (2018-2023)
14.3.3 Market Breakup by Technology
14.3.4 Market Breakup by Patient Type
14.3.5 Market Breakup by Indication
14.3.6 Market Breakup by Route of Administration
14.3.7 Market Breakup by Product Type
14.3.8 Market Breakup by Treatment Type
14.3.9 Market Breakup by End User
14.3.10 Market Breakup by Distribution Channel
14.3.11 Key Players
14.3.12 Market Forecast (2024-2032)
14.4 West
14.4.1 Overview
14.4.2 Historical and Current Market Trends (2018-2023)
14.4.3 Market Breakup by Technology
14.4.4 Market Breakup by Patient Type
14.4.5 Market Breakup by Indication
14.4.6 Market Breakup by Route of Administration
14.4.7 Market Breakup by Product Type
14.4.8 Market Breakup by Treatment Type
14.4.9 Market Breakup by End User
14.4.10 Market Breakup by Distribution Channel
14.4.11 Key Players
14.4.12 Market Forecast (2024-2032)
15 United States Vaccines Market – Competitive Landscape
15.1 Overview
15.2 Market Structure
15.3 Market Player Positioning
15.4 Top Winning Strategies
15.5 Competitive Dashboard
15.6 Company Evaluation Quadrant
16 Profiles of Key Players
16.1 Company A
16.1.1 Business Overview
16.1.2 Product Portfolio
16.1.3 Business Strategies
16.1.4 SWOT Analysis
16.1.5 Major News and Events
16.2 Company B
16.2.1 Business Overview
16.2.2 Product Portfolio
16.2.3 Business Strategies
16.2.4 SWOT Analysis
16.2.5 Major News and Events
16.3 Company C
16.3.1 Business Overview
16.3.2 Product Portfolio
16.3.3 Business Strategies
16.3.4 SWOT Analysis
16.3.5 Major News and Events
16.4 Company D
16.4.1 Business Overview
16.4.2 Product Portfolio
16.4.3 Business Strategies
16.4.4 SWOT Analysis
16.4.5 Major News and Events
16.5 Company E
16.5.1 Business Overview
16.5.2 Product Portfolio
16.5.3 Business Strategies
16.5.4 SWOT Analysis
16.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

17 United States Vaccines Market - Industry Analysis
17.1 Drivers, Restraints, and Opportunities
17.1.1 Overview
17.1.2 Drivers
17.1.3 Restraints
17.1.4 Opportunities
17.2 Porters Five Forces Analysis
17.2.1 Overview
17.2.2 Bargaining Power of Buyers
17.2.3 Bargaining Power of Suppliers
17.2.4 Degree of Competition
17.2.5 Threat of New Entrants
17.2.6 Threat of Substitutes
17.3 Value Chain Analysis
18 Appendix

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.